MR 409

Overview

MR 409 is a selected growth hormone-releasing hormone ( GHRH ) agonist. MR 409 has remarkable neuroprotective effects through enhancing endogenous neurogenesis in cerebral ischemic mice. MR 409 also inhibits the in vivo growth of lung cancer .

Application

Products | Products > Peptides | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Lung Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Signaling Pathways > GHR

Product Information

• Catalog No.: HY-P3304
• CAS No.: 1445155-39-4
• Molecular Formula: C153H252N44O43
• Molecular Weight: 3395.91
• Purity: 99.98%
• Storage: Sealed storage, away from moisture and light, under nitrogen. Powder -80°C, 2 years , -20°C, 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)
• Availability: In-stock

Source

Original product source